Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-4 of 4
Keywords: Toll-like receptor 4
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Ryan J. Stark, Hyehun Choi, Stephen R. Koch, Benjamin A. Fensterheim, Fred S. Lamb, Edward R. Sherwood
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (6): 451–461.
Published: 04 February 2016
... clinical benefit. The adjuvant monophosphoryl lipid A (MPLA) is a weak toll-like receptor 4 (TLR4) agonist that induces negligible inflammation but retains potent immunomodulatory properties. We postulated that pre-treatment with MPLA would inhibit the inflammatory response of endothelial cells...
Includes: Supplementary data
Articles
Mamoru Satoh, Yuji Takahashi, Tsuyoshi Tabuchi, Yoshitaka Minami, Makiko Tamada, Kan Takahashi, Tomonori Itoh, Yoshihiro Morino, Motoyuki Nakamura
Journal:
Clinical Science
Clin Sci (Lond) (2015) 129 (2): 93–105.
Published: 24 April 2015
... Journal compilation © 2015 Biochemical Society 2015 atherosclerosis endothelial progenitor cells miRNA SIRT-1 telomere toll-like receptor 4 As coronary artery disease (CAD) continues to be a leading cause of death around the world, primary and secondary prevention are of great...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (10): 685–694.
Published: 27 January 2014
... diabetic nephropathy inflammation kidney nuclear factor κB (NF-κB) Toll-like receptor 2 Toll-like receptor 4 Diabetic nephropathy is the leading cause of ESKD (end-stage kidney disease), affecting approximately one-third of all patients with diabetes mellitus [ 1 ]. The disease is relentlessly...
Articles
Mamoru SATOH, Motoyuki NAKAMURA, Tomonari AKATSU, Junji IWASAKA, Yudai SHIMODA, Ikuo SEGAWA, Katsuhiko HIRAMORI
Journal:
Clinical Science
Clin Sci (Lond) (2003) 104 (6): 577–584.
Published: 01 June 2003
... of the host immune response against viral pathogens has not been fully understood. The aim of the present study was to determine whether Toll-like receptor 4 (TLR4) and EV RNA are present in human myocarditis. Endomyocardial biopsy samples were obtained from 44 patients with myocarditis and five controls...
